Yes, I think those points that Mr. Buckley made are very interesting.
As a follow-up, I'm curious about this line between drugs and non-drugs and I'm curious about how it's defined in the United States. Maybe this shows my ignorance around the details of the issue, but where would your organization, Mr. Buckley, draw the line?
I would imagine that you would agree that pharmaceuticals—complex, sophisticated pharmaceutical drugs—should continue to be regulated as drugs. At the far extreme other end, you've used the example of water. Where should the line be drawn?